Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
12,743 Dovepress* 7,936 3,437+ 627 11,373
PubMed Central* 0 1,370 168 1,370
Totals 7,936 4,807 795 12,743
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
214 0 0 0 3 211

View citations on PubMed Central and Google Scholar